Estados financieros detallados de AIM ImmunoTech Inc. (AIM): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
AIM ImmunoTech Inc. registró ingresos de $88000 en el último ejercicio fiscal, con un CAGR de 5 años del -11.6%.
Márgenes de los últimos 12 meses: margen bruto -125.3%, margen operativo -116.4%, margen neto -150.2%.
Al precio actual de $0.21, AIM presenta beneficios negativos (P/E no significativo) y un ROE del 9.53%. La capitalización bursátil es de $1M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $92000 | $437000 | $367000 | $140000 | $163000 | $135000 | $141000 | $202000 | $170000 | $88000 |
| Coste de Ventas | $1.1M | $1.2M | $884000 | $893000 | $806000 | $850000 | 0 | $42000 | $31000 | $338000 |
| Beneficio Bruto | -$1.0M | -$746000 | -$517000 | -$753000 | -$643000 | -$715000 | $141000 | $160000 | $139000 | -$250000 |
| I+D | $5.1M | $4.1M | $4.8M | $4.7M | $5.7M | $7.7M | $7.0M | $10.9M | $6.2M | $3.9M |
| Generales y Administrativos | $7.7M | $6.6M | $6.2M | $7.0M | $8.7M | $8.7M | $13.1M | $21.1M | $13.7M | $7.7M |
| Gastos Operativos | $12.8M | $10.7M | $11.0M | $11.7M | $14.5M | $18.1M | $20.1M | $32.1M | $19.9M | $10.3M |
| Beneficio Operativo | -$13.8M | -$11.4M | -$11.5M | -$12.4M | -$15.2M | -$18.8M | -$19.9M | -$31.9M | -$19.8M | -$10.5M |
| EBITDA | -$6.3M | -$7.1M | -$8.4M | -$8.1M | -$13.0M | -$18.3M | -$19.2M | -$28.7M | -$16.5M | -$12.9M |
| Gastos por Intereses | 0 | $139000 | $502000 | $427000 | $672000 | $67000 | 0 | 0 | $585000 | $812000 |
| Beneficio Antes de Impuestos | -$7.5M | -$8.3M | -$9.8M | -$9.4M | -$14.4M | -$19.1M | -$19.4M | -$29.0M | -$17.3M | -$14.0M |
| Impuestos | 0 | 0 | $2.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$7.5M | -$8.3M | -$9.8M | -$9.4M | -$14.4M | -$19.1M | -$19.4M | -$29.0M | -$17.3M | -$14.0M |
| BPA | $-543.05 | $-463.19 | $-355.19 | $-93.71 | $-16.41 | $-14.67 | $-14.69 | $-21.64 | $-11.22 | $-8.62 |
| BPA Diluido | $-543.05 | $-463.19 | $-355.19 | $-93.71 | $-16.41 | $-14.67 | $-14.69 | $-21.64 | $-11.22 | $-8.62 |
| Acciones en Circulación (Diluidas) | $13669 | $17967 | $27689 | $100429 | $877903 | $1.3M | $1.3M | $1.3M | $1.5M | $1.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $26000 | $21000 | $22000 | $26000 |
| Beneficio Bruto | -$96000 | -$19000 | -$25000 | $21000 |
| Beneficio Operativo | -$2.4M | -$3.0M | -$2.2M | -$3.5M |
| EBITDA | -$3.1M | -$3.7M | -$2.7M | -$3.4M |
| Beneficio Neto | -$3.3M | -$4.2M | -$3.0M | -$3.8M |
| BPA | $-1.57 | $-1.36 | $-0.69 | $-0.22 |
| BPA Diluido | $-1.57 | $-1.36 | $-0.69 | $-0.22 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $2.4M | $1.4M | $299000 | $1.5M | $38.5M | $32.1M | $27.1M | $5.4M | $1.7M | $931000 |
| Inversiones a Corto | $3.5M | $695000 | $1.5M | $7.3M | $501000 | $16.2M | $7.1M | $7.6M | $2.3M | $62000 |
| Cuentas por Cobrar | 0 | $24000 | $1.1M | $820000 | $1.1M | $1.6M | $1.7M | $1.2M | 0 | $7000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$302000 | 0 | 0 |
| Activos Corrientes | $6.9M | $3.5M | $3.8M | $10.4M | $40.3M | $50.2M | $36.3M | $14.6M | $4.2M | $3.3M |
| Inmovilizado Material | $9.5M | $8.6M | $7.8M | $7.3M | $6.7M | $4.2M | $1.0M | $824000 | $726000 | $449000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $872000 | $858000 | $912000 | $1.2M | $1.5M | $2.0M | $1.9M | $2.3M | $2.6M | $1.7M |
| Activos Totales | $18.9M | $14.2M | $13.8M | $20.2M | $111.0M | $57.7M | $40.5M | $19.4M | $8.6M | $5.8M |
| Cuentas por Pagar | $887000 | $741000 | $680000 | $472000 | $383000 | $198000 | $377000 | $6.4M | $6.4M | $1.6M |
| Deuda a Corto | 0 | 0 | $3.6M | $214000 | $277000 | 0 | 0 | 0 | $2.3M | $3.8M |
| Pasivos Corrientes | $2.4M | $2.7M | $5.3M | $1.1M | $1.1M | $673000 | $1.4M | $8.7M | $9.5M | $6.2M |
| Deuda a Largo | 0 | $1.8M | 0 | $3.9M | 0 | 0 | 0 | 0 | 0 | $927000 |
| Pasivos Totales | $3.4M | $5.5M | $8.7M | $7.3M | $49.7M | $820000 | $2.0M | $9.1M | $9.9M | $15.6M |
| Reservas | -$300.5M | -$308.8M | -$318.6M | -$328.1M | -$342.0M | -$361.1M | -$380.5M | -$409.5M | -$426.8M | -$440.8M |
| Patrimonio Neto | $15.5M | $8.7M | $5.2M | $12.9M | $61.3M | $56.9M | $38.5M | $10.2M | -$1.3M | -$9.8M |
| Deuda Total | 0 | $1.8M | $5.9M | $6.4M | $2.3M | $149000 | $837000 | $718000 | $2.9M | $4.9M |
| Deuda Neta | -$5.9M | -$272000 | $4.1M | -$2.4M | -$36.7M | -$48.1M | -$33.4M | -$12.4M | -$1.0M | $3.9M |
| Capital Circulante | $4.5M | $798000 | -$1.5M | $9.3M | $39.2M | $49.5M | $35.0M | $5.9M | -$5.4M | -$2.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $2.3M | $931000 | $5.8M | $9.9M |
| Activos Totales | $5.5M | $5.8M | $8.6M | $12.7M |
| Pasivos Totales | $11.6M | $15.6M | $6.5M | $5.0M |
| Patrimonio Neto | -$6.1M | -$9.8M | $2.1M | $7.7M |
| Deuda Total | $2.3M | $4.9M | $4.6M | $3.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$7.5M | -$8.3M | -$9.8M | -$9.5M | -$14.4M | -$19.1M | -$19.4M | -$29.0M | -$17.3M | -$14.0M |
| Amortizaciones | $1.3M | $1.0M | $878000 | $792000 | $733000 | $659000 | $256000 | $238000 | $246000 | $210000 |
| Compensación en Acciones | $410000 | $571000 | $929000 | $853000 | $1.0M | $1.6M | $954000 | $243000 | $686000 | $60000 |
| Cambio en Capital Circulante | $29000 | $1.1M | -$2.1M | -$543000 | $605000 | $1.1M | $966000 | $7.1M | $296000 | -$878000 |
| Flujo de Caja Operativo | -$7.4M | -$7.9M | -$10.6M | -$9.1M | -$10.4M | -$14.0M | -$16.1M | -$21.3M | -$14.9M | -$11.0M |
| Inversiones (CapEx) | -$454000 | -$69000 | -$127000 | -$365000 | -$595000 | -$41000 | -$271000 | -$585000 | -$18000 | -$378000 |
| Adquisiciones | 0 | 0 | $755000 | 0 | $573000 | 0 | 0 | $47000 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.8M | -$8.0M | -$10.8M | -$9.4M | -$11.0M | -$14.0M | -$16.4M | -$21.9M | -$14.9M | -$11.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.1M | -$2.0M | -$2.7M | $2.7M |
| Inversiones (CapEx) | 0 | -$95000 | -$35000 | $35000 |
| Flujo de Caja Libre | -$5.1M | -$2.1M | -$2.8M | $2.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | 0 | 0 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +375.0% | -16.0% | -61.9% | +16.4% | -17.2% | +4.4% | +43.3% | -15.8% | -48.2% |
| Crecimiento Beneficio Neto (anual) | | -10.1% | -18.8% | +4.2% | -53.1% | -32.8% | -1.7% | -48.9% | +40.2% | +19.4% |
| Crecimiento BPA (anual) | | +14.7% | +23.3% | +73.6% | +82.5% | +10.7% | -0.2% | -47.3% | +48.1% | +23.2% |
| Cambio en Acciones (anual) | | +31.4% | +54.1% | +262.7% | +774.2% | +48.7% | +1.5% | +1.1% | +15.3% | +4.8% |
| Crecimiento FCF (anual) | | -2.2% | -34.4% | +12.4% | -16.2% | -27.8% | -16.9% | -33.4% | +31.8% | +24.0% |
| Margen Bruto | -1104.3% | -170.7% | -140.9% | -537.9% | -394.5% | -529.6% | 100.0% | 79.2% | 81.8% | -284.1% |
| Margen Operativo | -15004.3% | -2612.4% | -3132.4% | -8887.9% | -9295.7% | -13954.1% | -14129.7% | -15800.0% | -11630.6% | -11961.4% |
| Margen EBITDA | -6883.7% | -1628.4% | -2290.2% | -5820.0% | -7972.4% | -13544.4% | -13609.2% | -14219.8% | -9699.4% | -14700.0% |
| Margen Neto | -8154.3% | -1889.9% | -2673.8% | -6717.1% | -8834.4% | -14168.1% | -13790.8% | -14337.6% | -10188.2% | -15861.4% |
| Margen FCF | -8515.2% | -1833.0% | -2933.8% | -6737.1% | -6725.8% | -10374.8% | -11616.3% | -10817.8% | -8768.2% | -12880.7% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -22.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-573.11 | $-445.81 | $-388.86 | $-93.92 | $-12.49 | $-10.73 | $-12.36 | $-16.31 | $-9.65 | $-7.00 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $13669 | $17967 | $27689 | $100429 | $877903 | $1.3M | $1.3M | $1.3M | $1.5M | $1.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 952.76% |
| Rentabilidad sobre capital invertido | -94.78% |
| Rentabilidad sobre activos | -112.09% |
| Margen bruto | -125.26% |
| Margen operativo | -11637.89% |
| Margen neto | -15021.05% |
Salud financiera
| Deuda / Patrimonio | 0.51 |
| Ratio corriente | 2.11 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -5.26 | -3.13 | -2.10 | -0.54 | -10.26 | -5.90 | -1.99 | -1.91 | -1.68 | -0.13 |
| P/VC | 2.52 | 2.99 | 3.99 | 0.40 | 2.41 | 1.99 | 1.00 | 5.42 | -21.99 | -0.19 |
| P/V | 424.36 | 59.57 | 56.21 | 36.45 | 906.99 | 836.75 | 274.05 | 274.53 | 170.97 | 20.78 |
| Margen Bruto | -1104.3% | -170.7% | -140.9% | -537.9% | -394.5% | -529.6% | 100.0% | 79.2% | 81.8% | -284.1% |
| Margen Operativo | -15004.3% | -2612.4% | -3132.4% | -8887.9% | -9295.7% | -13954.1% | -14129.7% | -15800.0% | -11630.6% | -11961.4% |
| Margen Neto | -8154.3% | -1889.9% | -2673.8% | -6717.1% | -8834.4% | -14168.1% | -13790.8% | -14337.6% | -10188.2% | -15861.4% |